BPCR.L
Price:
$0.9056
Market Cap:
$1.02B
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.
Industry
Asset Management
IPO Date
2017-03-27
Stock Exchange
LSE
Ticker
BPCR.L
According to BioPharma Credit PLC’s latest financial reports and current stock price. The company's current Enterprise Value is 1.02B. This represents a change of 32.32% compared to the average of 768.65M of the last 4 quarters.
The mean historical Enterprise Value of BioPharma Credit PLC over the last ten years is 1.04B. The current 1.02B Enterprise Value has changed 9.65% with respect to the historical average. Over the past ten years (40 quarters), BPCR.L's Enterprise Value was at its highest in in the June 2022 quarter at 2.57B. The Enterprise Value was at its lowest in in the December 2024 quarter at -5620000.00.
Average
1.04B
Median
1.11B
Minimum
454.52M
Maximum
1.24B
Discovering the peaks and valleys of BioPharma Credit PLC Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 143.45%
Maximum Annual Enterprise Value = 1.24B
Minimum Annual Increase = -14.43%
Minimum Annual Enterprise Value = 454.52M
Year | Enterprise Value | Change |
---|---|---|
2024 | 1.07B | 6.04% |
2023 | 1.01B | -14.43% |
2022 | 1.18B | -4.09% |
2021 | 1.24B | 5.11% |
2020 | 1.18B | 6.37% |
2019 | 1.10B | -0.16% |
2018 | 1.11B | 143.45% |
The current Enterprise Value of BioPharma Credit PLC (BPCR.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.09B
5-year avg
1.14B
10-year avg
1.04B
BioPharma Credit PLC’s Enterprise Value is greater than JLEN Environmental Assets Group Limited (482.61M), less than Sequoia Economic Infrastructure Income Fund Limited (1.26B), greater than CQS New City High Yield Fund Limited (340.67M), less than HICL Infrastructure PLC (2.38B), greater than Bluefield Solar Income Fund Limited (563.37M),
Company | Enterprise Value | Market cap |
---|---|---|
482.61M | $611.61M | |
1.26B | $1.26B | |
340.67M | $312.20M | |
2.38B | $2.38B | |
563.37M | $564.45M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioPharma Credit PLC using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioPharma Credit PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BioPharma Credit PLC's Enterprise Value?
What is the highest Enterprise Value for BioPharma Credit PLC (BPCR.L)?
What is the 3-year average Enterprise Value for BioPharma Credit PLC (BPCR.L)?
What is the 5-year average Enterprise Value for BioPharma Credit PLC (BPCR.L)?
How does the current Enterprise Value for BioPharma Credit PLC (BPCR.L) compare to its historical average?